RBP4 is thought be related to obesity, insulin resistance, type-2 diabetes, and metabolic syndrome (33) and is suggested to be an early indicator of the development of insulin resistance and metabolic syndrome, and that this adiponectin is more sensitive to insulin than leptin, IL-6, and CRP (34). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.